NEUROLYTIC CELIAC PLEXUS BLOCK FOR TREATMENT OF CANCER PAIN - A METAANALYSIS
NEUROLYTIC CELIAC PLEXUS BLOCK FOR TREATMENT OF CANCER PAIN - A METAANALYSIS
复制标题
DOI：
10.1097/00000539-199502000-00015
复制
发表时间：
1995-02-01
影响因子：
5.7
通讯作者：
CHALMERS, TC
中科院分区：
文献类型：
--
作者：
EISENBERG, E;CARR, DB;CHALMERS, TC
我们进行了一项关于神经松解性腹丛神经阻滞(NCPB)治疗癌症疼痛的有效性和安全性的荟萃分析。文献搜索得到59篇文章，但只有24篇文章可以获得有关两名或更多患者的NCPB数据。21项研究为回顾性研究，1项为前瞻性研究，2项为随机对照研究。在报告的1145例患者中，1117例表明了癌症类型(63%是胰腺癌，37%是非胰腺癌)。双侧后入路150~50mT 50%~100%酒精是最常见的方法。246例(32%)患者接受了非放射引导下的NCPB，214例(28%)接受了CT引导，271例(34%)接受了X线片引导，36例(5%)接受了透视检查，7例(5%)接受了超声引导(7%)。
We performed a meta-analysis of the efficacy and safety of neurolytic celiac plexus block (NCPB) for cancer pain. A literature search yielded 59 papers, but data on NCPB in two or more patients was available in only 24 papers. Twenty-one studies were retrospective, one was prospective, and two were randomized and controlled. Cancer type was stated in 1117 of 1145 patients reported (63% pancreatic, 37% nonpancreatic). A bilateral posterior approach with 150-50 mt of 50%-100% alcohol was the most common technique. Nonradiologically guided NCPB was performed in 246 patients (32%); guidance was by computed tomography (CT) in 214 (28%), radiograph in 271 (34%), fluoroscopy in 36 (5%), or ultrasound in 7 (